in my role at fighting blindness canada, i see this every day within our very own community of vision loss patients and their families. the story of charmain is one that stands out for me. she’s a mother of two vibrant teens who were both born with retinitis pigmentosa, a genetic disorder that can lead to vision loss. while both jenna and adam are successful and happy young adults, charmain says watching them navigate the systemic barriers around them is a constant challenge.
while jenna was able to qualify for a clinical trial that saved her sight in one eye, adam is still waiting for a life-changing, sight-improving treatment. the science is there — but it’s not accessible because it’s not a publicly-funded treatment.
“to us, access to this treatment is a necessity,” says charmain. “on a personal level, it will help them both maintain their quality of life and independence. it will allow them to gain and maintain employment. and from a pragmatic societal standpoint, it will reduce their need for further government assistance.”
the difference access to eye exams and therapies makes
when eye exams and innovative therapies are accessible, it can make a world of difference for people like adam and jenna.
vision loss not only has devastating impacts on the individual, but the economic costs of inaction are also impossible to ignore. the economic and well-being
cost of vision loss in canada was $32.9 billion in 2019 and projections of trends in population growth and aging show that this cost is expected to rise.
accessibility to eye care services, including timely eye examinations and treatments, is essential in reducing the incidence and slowing the progression of vision loss.
it’s for these reasons that
fighting blindness canada, the canadian council of the blind, and novartis pharmaceuticals canada have partnered to launch the “all eyes on you” awareness campaign. we’re urging canadians to understand this issue, prioritize their eye health and call on the government to act.